IL1B and breast carcinoma: In contrast, the IL-1β/IL-1R1/β-catenin signaling pathway that regulates c-MYC, cyclin D1 (CCDN1), SNAIL1, and matrix metallopeptidases (MMP) 2 expression promotes proliferation, migration, and invasion in breast cancer [37].